Meridian bioscience stock.

Jan 31, 2023 · Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. ("SDB") (KOSE: A137310) and SJL Partners ... Jul 8, 2022 · Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ... Meridian Bioscience hits 52-week high; stock up 36% YTD SA News Wed, Jun. 08, 2022 2 Comments. Meridian Biosciences says its qPCR mixes can be used in monkeypox molecular testsMeridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] 31, 2023 · About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products.

Jan 31, 2023 · The estimated Net Worth of Dwight E Ellingwood is at least $379 Tisíc dollars as of 4 October 2018. Mr. Ellingwood owns over 1,000 units of Meridian Bioscience stock worth over $271,760 and over the last 9 years he sold VIVO stock worth over $0. In addition, he makes $107,000 as Independent Director at Meridian Bioscience.Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Dec 19, 2022 · The estimated Net Worth of Bryan T Baldasare is at least $2.96 Million dollars as of 8 February 2021. Mr. Baldasare owns over 6,254 units of Meridian Bioscience stock worth over $1,906,668 and over the last 4 years he sold VIVO stock worth over $566,813. In addition, he makes $490,759 as Chief Financial Officer, Senior Vice …

Meridian Bioscience Inc. Common Stock (VIVO) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.

Dec 1, 2023 · Meridian Bioscience, Inc. (NASDAQ:VIVO) issued its earnings results on Friday, November, 12th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.03. The company had revenue of $76.20 million for the quarter, compared to analysts' expectations of $68.40 million. Zacks Premium Feature View All Zacks #1 Ranked Stocks · Meridian Bioscience Inc. (VIVO) Quote Overview » Zacks Research » Meridian Bioscience Inc. (VIVO) ...Jan 31, 2023 · The estimated Net Worth of Anthony P Iii Bihl is at least $2.24 Million dollars as of 17 May 2022. Mr. Bihl owns over 20,000 units of Meridian Bioscience stock worth over $2,242,020 and over the last 7 years he sold VIVO stock worth over $0. In addition, he makes $0 as Independent Director at Meridian Bioscience.The stock of Meridian Bioscience (NAS:VIVO, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation.

37.23M. MSFT. 378.61. +0.31%. 20.54M. View today's Meridian Bioscience Inc stock price and latest VIVO news and analysis. Create real-time notifications to follow any changes in the live stock price.

1.1 This Israeli Appendix (the “Appendix”) to the Meridian Bioscience, Inc. 2012 Stock Incentive Plan, as amended from time to time (the “Plan”) is made and entered effective as of July 10, 2020 (the “Appendix Effective Date”). The provisions specified hereunder shall form an integral part of the Plan. 1.2 The provisions set forth in this Appendix apply only …

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? Feb 1, 2023 · Feb 1, 2023. In vitro diagnostics company SD Biosensor and private equity investment firm SJL Partners announced on Tuesday that they have completed their acquisition of Cincinnati-based life science company Meridian Bioscience. The acquisition was agreed upon in July 2022 as an all-cash transaction valued at approximately $1.53 billion. Meridian Bioscience Inc (NASDAQ:VIVO) has agreed to acquire the North American BreathTek business from Otsuka America Pharmaceutical Inc for $20 million in cash.; The transaction will close in ...Check if VIVO Stock has a Buy or Sell Evaluation. VIVO Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Meridian Bioscience Inc. News.17 Mei 2016 ... Preparing the PCR primer stock and mixes. Hands-on DNA•36K views · 9:39 · Go ... Bioline: Meridian Bioscience•1.2K views · 12:16 · Go to channel ...Mr. Phillips VIVO stock SEC Form 4 insiders trading. David has made over 8 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 7,500 units of VIVO stock worth $139,050 on 12 January 2022.. The largest trade he's ever made was buying 10,000 units of Meridian …

Stock price history for Meridian Bioscience (VIVO) Highest end of day price: $35.90 USD on 2008-04-08. Lowest end of day price: $0.35 USD on 1987-12-08. Stock price history of Meridian Bioscience from 1986 to 2023. Stock price for similar companies or competitors. Company Stock priceDec 19, 2022 · The estimated Net Worth of Bryan T Baldasare is at least $2.96 Million dollars as of 8 February 2021. Mr. Baldasare owns over 6,254 units of Meridian Bioscience stock worth over $1,906,668 and over the last 4 years he sold VIVO stock worth over $566,813. In addition, he makes $490,759 as Chief Financial Officer, Senior Vice …Meridian Bioscience is committed to working with and providing reasonable accommodation to individuals with physical and mental disabilities. If you need special assistance or an accommodation while seeking employment, please email [email protected] or call 513-271-3700. We will make a …28 août 2021 ... Get the latest news and market analysis for Meridian Bioscience, Inc. (VIVO). Stay up-to-date on VIVO Stock price and share price with ...Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] Meridian Bioscience, Inc. - Deutsche Boerse AG. Meridian Bioscience, Inc. (MR4.FRA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for …Feb 10, 2022 · But on the bright side, you can make far more than 100% on a really good stock. For example, the Meridian Bioscience, Inc. (NASDAQ:VIVO) share price has soared 108% in the last half decade. Most ...

John Kraeutler VIVO stock SEC Form 4 insiders trading. John has made over 11 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently John bought 7,000 units of VIVO stock worth $95,690 on 24 August 2017.. The largest trade John's ever made was exercising 48,820 units of Meridian …Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...

Dec 31, 2022 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies ... CINCINNATI, Dec. 12, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has ...Company profile page for Meridian Bioscience Corp including stock price, company news, press releases, executives, board members, and contact information Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? The opportunity to support authentic relationships is what motivates our teams to create accurate solutions that span the range from discovery to diagnosis. We work hard every day to build genuine connections with all of our customers because even in the complex world of healthcare, the solution is simple. We’re here to help people, and we ... Mar 24, 2016 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... As a publicly traded company, ownership of Meridian Bioscience, Inc. is constantly changing as shares are bought and sold on the stock market.Meridian Bioscience, Inc. (VIVO) Mission Statement The mission of Meridian Bioscience, Inc. is to provide diagnostic test kits, reagents, and related products and services that are of the highest quality ...14 déc. 2020 ... For Immediate ReleaseChicago, IL – December 14, 2020 – Stocks in this week's article are Meridian Bioscience, Inc. VIVO, Piper Sandler ...Stock VIVO January 30, 2023 NASDAQ 20 minutes delay $33.97 Open 33.95 ... Meridian Bioscience Inc. | 18,715 followers on LinkedIn.

Stock split history for Meridian Bioscience (VIVO) Meridian Bioscience stock (symbol: VIVO) underwent a total of 7 stock splits. The most recent stock split occured on May 14th, 2007. One VIVO share bought prior to March 30th, 1992 would equal to 5.47509375 VIVO shares today. Stock split list. Date

All series of Meridian Bioscience, Inc. options whose expiration dates are after 02-17-2023 will have their expiration dates advanced to 02-17-2023. Expiration dates occurring before 02-17-2023 (e.g., Flex options) will remain unchanged. All Meridian Bioscience, Inc. options will utilize a $.01 exercise threshold. Option Symbol: VIVO

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com. Meridian Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] 8, 2022 · Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ... Parallel is an alternate term for a line of latitude on a map, while meridian is an alternate term for a line of longitude. Lines of latitude are located parallel to the Equator and never intersect, which is why they are also called paralle...Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, …Meridian Bioscience has 5 employees across 11 locations and $333.02 m in annual revenue in FY 2022. See insights on Meridian Bioscience including office locations, competitors, ... Stock Price. $34. 2023-01-30. Market Capitalization. $1.5 B. 2023-01-30. Revenue. $333 M. FY, 2022.North Billerica, MA. •Assists customers with the implementation of systems purchased from Meridian Bioscience. •Provide technical product support as well as product training to external and ...May 3, 2019 · View %COMPANY_NAME% VIVO investment & stock information. Get the latest %COMPANY_NAME% VIVO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... Meridian Bioscience Inc ... Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...

Meridian Bioscience Inc. (VIVO) Stock Price, News & Historical Data - TheStreet November 26, 2023 [ Healthcare ] [ Medical Diagnostics & Research ] [ VIVO ] Meridian Bioscience Inc. VIVO...As a publicly traded company, ownership of Meridian Bioscience, Inc. is constantly changing as shares are bought and sold on the stock market.Meridian Bioscience, Inc. (VIVO) Mission Statement The mission of Meridian Bioscience, Inc. is to provide diagnostic test kits, reagents, and related products and services that are of the highest quality ...Jan 31, 2023 · John Rice owns over 27,205 units of Meridian Bioscience stock worth over $1,389,950 and over the last 6 years he sold VIVO stock worth over $0. In addition, he makes $103,000 as Independent Director at Meridian Bioscience. Wallmine is a radically better financial terminal. Sign up in seconds, it's free!Financial performance achieved by Meridian Bioscience has been rather interesting. After seeing revenue remain almost flat, bouncing around within a range of between $200.8 million and $213.6 ...Instagram:https://instagram. how to buy stock in airbnbwhere to buy traction uranium stockbarc share pricejohnson and johnson and kenvue Zacks Premium Feature View All Zacks #1 Ranked Stocks · Meridian Bioscience Inc. (VIVO) Quote Overview » Zacks Research » Meridian Bioscience Inc. (VIVO) ... wood speed boattarget's prices SD Biosensor and SJL Partners agreed to acquire Meridian Bioscience in an all-cash deal valued at about $1.53 billion, according to a statement by Cincinnati-based Meridian on Thursday.. SD Biosensor, a diagnostics company headquartered in South Korea, along with private equity firm SJL Partners, would create a new affiliate for the … clm dividends CINCINNATI, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that based on preliminary results, it expe...Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least 365 千$ dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over 261,569$ and over the last 8 years she sold VIVO stock worth over 0$. In addition, she makes 103,333$ as Independent Director at Meridian Bioscience.Track Meridian Bioscience Inc. (VIVO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors